ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in ProQR Therapeutics N.V. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- 0 vs. Q1 2024
- Shares held
- 17.3M
- −92.5K (−0.5%) vs. Q1 2024
- Total value
- $28.6M
- −$11.1M (−28.0%) vs. Q1 2024
- New holders
- 3
- 5 more added
- Sold out
- 3
- 17 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 276 | $0 | 0.00% | −3,871−93.3% | Reduced |
| Qube Research & Technologies Ltd | 33 | $55 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 314 | $521 | 0.00% | −1,179−79.0% | Reduced |
| Tower Research Capital LLC (TRC) | 821 | $1.36K | 0.00% | +821 | New |
| PFS Partners, LLC | 1,000 | $1.66K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,055 | $2.00K | 0.00% | +855+427.5% | Added |
| Acadian Asset Management LLC | 3,933 | $6.00K | 0.00% | −20,830−84.1% | Reduced |
| BlackRock Inc. | 3,945 | $6.55K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,090 | $6.79K | 0.00% | −5,600−57.8% | Reduced |
| Simplex Trading, LLC | 6,628 | $11.0K | 0.00% | −6,922−51.1% | Reduced |
| Truist Financial Corp | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,996 | $18.3K | 0.00% | 00.0% | Unchanged |
| EP Wealth Advisors, LLC | 11,500 | $19.1K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12,250 | $20.3K | 0.00% | −561−4.4% | Reduced |
| Two Sigma Securities, LLC | 12,471 | $20.7K | 0.00% | −11,262−47.5% | Reduced |
| Atom Investors LP | 13,107 | $21.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,932 | $26.4K | 0.00% | −1,488−8.5% | Reduced |
| Mariner, LLC | 18,334 | $30.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,365 | $30.5K | 0.00% | −27,643−60.1% | Reduced |
| JustInvest LLC | 21,429 | $35.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 27,546 | $45.7K | 0.00% | +22,576+454.2% | Added |
| RFG Advisory, LLC | 32,000 | $53.1K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 30,000 | $53.4K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 42,000 | $69.7K | 0.00% | −3,000−6.7% | Reduced |
| Geode Capital Management, LLC | 46,671 | $77.5K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 51,501 | $85.5K | 0.00% | +16,500+47.1% | Added |
| Schonfeld Strategic Advisors LLC | 61,900 | $102.8K | 0.00% | +61,900 | New |
| Two Sigma Investments, LP | 68,945 | $114.4K | 0.00% | −9,999−12.7% | Reduced |
| Bank of America Corp | 73,163 | $121.5K | 0.00% | −36,944−33.6% | Reduced |
| Morgan Stanley | 77,942 | $129.4K | 0.00% | +10,351+15.3% | Added |
| Squarepoint Ops LLC | 84,733 | $140.7K | 0.00% | −67,769−44.4% | Reduced |
| Susquehanna International Group, LLP | 96,118 | $159.6K | 0.00% | −44,033−31.4% | Reduced |
| Boothbay Fund Management, LLC | 106,703 | $177.1K | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 131,500 | $218.3K | 0.00% | −30,500−18.8% | Reduced |
| Millennium Management LLC | 148,357 | $246.3K | 0.00% | −180,632−54.9% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $249.0K | 0.02% | 00.0% | Unchanged |
| Monaco Asset Management SAM | 312,629 | $519.0K | 0.26% | 00.0% | Unchanged |
| Deutsche Bank AG | 385,149 | $639.3K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 483,583 | $802.7K | 0.25% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $1.03M | 0.00% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 900,000 | $1.49M | 0.52% | +900,000 | New |
| DAFNA Capital Management LLC | 905,582 | $1.50M | 0.36% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,019,498 | $1.69M | 2.19% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,042,771 | $3.39M | 0.10% | −841,586−29.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $6.02M | 0.01% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 5,580,725 | $9.21M | 2.35% | +236,279+4.4% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,943−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −12,053−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |